Baseline Characteristics of Participants in the ASPREE (ASPirin in Reducing Events in the Elderly) Study

BACKGROUND: There are no primary prevention trials of aspirin with relevant geriatric outcomes in elderly people. ASPirin in Reducing Events in the Elderly (ASPREE) is a placebo-controlled trial of low-dose aspirin that will determine whether 5 years of daily 100-mg enteric-coated aspirin extends di...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Gerontol A Biol Sci Med Sci
Main Authors: McNeil, John J, Woods, Robyn L, Nelson, Mark R, Murray, Anne M, Reid, Christopher M, Kirpach, Brenda, Storey, Elsdon, Shah, Raj C, Wolfe, Rory S, Tonkin, Andrew M, Newman, Anne B, Williamson, Jeff D, Lockery, Jessica E, Margolis, Karen L, Ernst, Michael E, Abhayaratna, Walter P, Stocks, Nigel, Fitzgerald, Sharyn M, Trevaks, Ruth E, Orchard, Suzanne G, Beilin, Lawrence J, Donnan, Geoffrey A, Gibbs, Peter, Johnston, Colin I, Grimm, Richard H
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
The Journal of Gerontology: Medical Sciences
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5861878/
https://ncbi.nlm.nih.gov/pubmed/28329340
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/gerona/glw342
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados